Dunbar Pharma Brings Plant-Derived Dronabinol to the UK

Dunbar brings plant-derived dronabinol API to UK

Dunbar Pharma has introduced its plant-derived dronabinol active pharmaceutical ingredient into the UK through a supply agreement with IPS Pharma, extending commercial-scale output from its EU-GMP-certified Irish operation into a second major European market. IPS will use the API to manufacture cannabis-based medicinal products supplied through the UK Specials pathway. The material, marketed as WaterClear THC, is produced in Athlone under Health…

Dunbar Pharma Brings Plant-Derived Dronabinol to the UK

Dunbar Pharma Brings Plant-Derived Dronabinol to the UK Through IPS PharmaFor patients who use cannabinoid medicines but cannot—or simply do not want to—inhale them, pharmaceutical-grade oral options can be critical. Dunbar Pharmaceuticals is now widening access to those alternatives in the United Kingdom with the launch of WaterClear THC™, its plant-derived dronabinol active pharmaceutical ingredient (API), through IPS Pharma.The partnership co…